the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
January 14, 2017 – Is there an increased risk of bladder cancer with pioglitazone-containing medicines? Some (most) drug regulatory agencies worldwide do think so. However, the actions taken vary considerably. The example of the French ANSM (L’Agence nationale de …
Pioglitazone: Too often ending in bladder cancer? Read more »
June 20, 2011 – The American Food and Drug Administration (FDA) informed recently (on June 15, 2011) that the use of the diabetes medication Pioglitazone [Actos] for more than one year may be associated with an increased risk of bladder …
July 04, 2010 – The arthritis pill Rofecoxib [Vioxx] was withdrawn from the market but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when …